Great announcement and the switch to targeting cancer pain where we know fetanyl derived products have dominated is a good move. Alot of them have been pulled from shelves which will leave a big gap in the market in the coming years which gives inhalerx a chance to fill the void......
IND submission is overdue and should be lodged any day now!!!
- Forums
- ASX - By Stock
- IRX
- Ann: IRX211 - Targeted Pain Indication Nomination - BTcP
Ann: IRX211 - Targeted Pain Indication Nomination - BTcP, page-2
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IRX (ASX) to my watchlist
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.072M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 210118 | 3.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.6¢ | 130000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 210118 | 0.032 |
1 | 57943 | 0.030 |
1 | 200000 | 0.028 |
1 | 300000 | 0.023 |
2 | 439999 | 0.020 |
Price($) | Vol. | No. |
---|---|---|
0.036 | 130000 | 1 |
0.040 | 58388 | 1 |
0.042 | 244870 | 1 |
0.044 | 400000 | 1 |
0.050 | 400555 | 2 |
Last trade - 16.12pm 11/09/2024 (20 minute delay) ? |
Featured News
IRX (ASX) Chart |
Day chart unavailable